The London-based platform, which already covers 1.5 million eligible lives across enterprise and healthcare deployments, is using the Series A to accelerate US market entry and deepen its clinical inf [...]
The prevailing assumption in AI development has been straightforward: larger models trained on more data produce better results. Nvidia's latest release directly challenges that size assumption â [...]